Tag: generic drugs

25 Feb 2026

Why Generic Drugs Look Different: The Role of Trademark Laws

Generic drugs look different from brand-name ones not because they’re inferior, but because U.S. trademark law requires them to. This ensures no two drugs look identical, while still guaranteeing they work the same. Learn why the color, shape, or size of your pill might change-and why it’s completely safe.

Read More
3 Feb 2026

Retail vs Hospital Pharmacy: Key Differences in Medication Substitution Practices

Retail and hospital pharmacies handle medication substitution in fundamentally different ways - one driven by cost and convenience, the other by clinical safety and coordination. Understanding these differences is key to safe, effective patient care.

Read More
28 Jan 2026

Patent Litigation and Generic Entry: Why Drug Disputes Delay Affordable Medicines

Patent litigation delays generic drug launches by years, even after FDA approval. Brand-name companies use legal tactics like patent thickets and pay-for-delay deals to extend monopolies, keeping prices high and patients waiting.

Read More
20 Dec 2025

How Advertising Shapes Perceptions of Generic Medications

Advertising for brand-name drugs shapes patient and doctor perceptions, making generics seem inferior-even though they’re chemically identical. Learn how marketing tricks influence prescriptions and what you can do to choose wisely.

Read More
26 Nov 2025

Provider Case Studies: Real Experiences with Generic Medications

Real provider experiences with generic medications reveal that while most generics work just as well as brand-name drugs, patient trust, state regulations, and formulation differences can impact outcomes - especially for narrow therapeutic index drugs.

Read More
12 Nov 2025

Pharmacokinetic Studies: The Real Standard for Proving Generic Drug Equivalence

Pharmacokinetic studies are the primary method used to prove generic drugs work like brand-name versions, but they’re not foolproof. Learn how they work, where they fall short, and what’s changing in drug approval.

Read More